CPC Subgroup
A61K 31/40 having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Full Title
Medicinal preparations containing organic active ingredients > Heterocyclic compounds > having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins > having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
7 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 31/401 Proline; Derivatives thereof, e.g. captopril
- A61K 31/4015 having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
- A61K 31/402 1-aryl substituted, e.g. piretanide
- A61K 31/4025 not condensed and containing further heterocyclic rings, e.g. cromakalim
- A61K 31/403 condensed with carbocyclic rings, e.g. carbazole
- A61K 31/407 condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A61K 31/409 having four such rings, e.g. porphine derivatives, bilirubin, biliverdine (hemin, hematin A61K31/555)
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513